Geron Corp (NASDAQ:GERN)

1.37
Delayed Data
As of 3:59pm ET
 -0.05 / -3.52%
Today’s Change
1.20
Today|||52-Week Range
2.36
-13.84%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$455.3M

Company Description

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Contact Information

Geron Corp.
919 East Hillsdale Boulevard
Foster City California 94404
P:(650) 473-7700
Investor Relations:

Employees

Shareholders

Individual stakeholders3.13%
Mutual fund holders19.43%
Other institutional18.32%

Top Executives

John A. ScarlettChairman, President & Chief Executive Officer
Andrew J. GrethleinChief Operating Officer & Executive Vice President
Olivia K. BloomChief Financial Officer, Treasurer & Executive VP
Aleksandra RizoChief Medical Officer & Executive Vice President
Melissa A. Kelly BehrsChief Business Officer & Executive Vice President